Michael E. Mullins. (2021) Physostigmine should be used more readily for antimuscarinic toxicity: CON. British Journal of Clinical Pharmacology 88:1, pages 61-63.
Crossref
Sharon L. Crowell‐Davis, Thomas F. Murray & Leticia Mattos DantasSharon L. Crowell‐Davis. 2019. Veterinary Psychopharmacology. Veterinary Psychopharmacology
231
256
.
William J. Boroughf. 2017. Critical Care Toxicology. Critical Care Toxicology
2943
2955
.
Andrew H. Dawson & Nicholas A. Buckley. (2015) Pharmacological management of anticholinergic delirium ‐ theory, evidence and practice. British Journal of Clinical Pharmacology 81:3, pages 516-524.
Crossref
William J. Boroughf. 2016. Critical Care Toxicology. Critical Care Toxicology
1
14
.
Joseph W. Watkins, Evan S. Schwarz, Anna M. Arroyo-Plasencia & Michael E. Mullins. (2014) The Use of Physostigmine by Toxicologists in Anticholinergic Toxicity. Journal of Medical Toxicology 11:2, pages 179-184.
Crossref
D. ERIC BRUSH & CYNTHIA K. AARON. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
537
548
.
Donna L Seger. (2006) A Critical Reconsideration of the Clinical Effects and Treatment Recommendations for Sodium Channel Blocking Drug Cardiotoxicity. Toxicological Reviews 25:4, pages 283-296.
Crossref
Sharon Crowell‐Davis & Thomas Murray. 2005. Veterinary Psychopharmacology. Veterinary Psychopharmacology
179
206
.
Nicole L. Ries & Richard C. Dart. (2005) New Developments in Antidotes. Medical Clinics of North America 89:6, pages 1379-1397.
Crossref
Jeffrey R Suchard. (2003) Assessing physostigmine’s contraindication in cyclic antidepressant ingestions. The Journal of Emergency Medicine 25:2, pages 185-191.
Crossref
David J. Triggle, John M. Mitchell & Ron Filler. (1998) The Pharmacology of Physostigmine. CNS Drug Reviews 4:2, pages 87-136.
Crossref
Joseph H. Flaherty. (1998) Commonly Prescribed and Over-The-Counter Medications: Causes of Confusion. Clinics in Geriatric Medicine 14:1, pages 101-128.
Crossref
Henry Cohen, Robert S. Hoffman & Mary Ann Howland. (2016) Antidepressant Poisoning and Treatment: A Review and Case Illustration. Journal of Pharmacy Practice 10:4, pages 249-270.
Crossref
K. Knudsen. 1996. Human Toxicology. Human Toxicology
301
317
.
Daniela Amital & R.H Belmaker. (1994) Lithium involvement in physostigmine-induced seizures. Biological Psychiatry 36:7, pages 498.
Crossref
Henry Cohen, Robert S. Hoffman & Mary Ann Howland. (2016) Cyclic Antidepressant Poisoning: A Review and Case Report. Journal of Pharmacy Practice 6:2, pages 89-102.
Crossref
Stephanie A. Miller, Dennis W. Blick, Sandra Z. Kerenyi & Michael R. Murphy. (1993) Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacology Biochemistry and Behavior 44:2, pages 343-347.
Crossref
Lori K. Danze & Mark I. Lanqdorf. (1991) Reversal of orphenadrine-induced ventricular tachycardia with physostigmine. The Journal of Emergency Medicine 9:6, pages 453-457.
Crossref
Farid J. Muhtadi & Seham S. El-Hawary. 1990.
289
350
.
Garrett E. Foulke, Timothy E. Albertson & William F. Walby. (1986) Tricyclic antidepressant overdose: Emergency department findings as predictors of clinical course. The American Journal of Emergency Medicine 4:6, pages 496-500.
Crossref
Peter Crome. (2012) Poisoning Due to Tricyclic Antidepressant Overdosage. Medical Toxicology 1:4, pages 261-285.
Crossref
Wesley G. Clark & J.M. Lipton. (1986) Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants: II. Neuroscience & Biobehavioral Reviews 10:2, pages 153-220.
Crossref
Michael Callaham. (1985) Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Annals of Emergency Medicine 14:1, pages 1-9.
Crossref
Toby L. Litovitz. (1984) The Anecdotal Antidotes. Emergency Medicine Clinics of North America 2:1, pages 145-158.
Crossref
Carlton K. Erickson. 1983. The Biology of Alcoholism. The Biology of Alcoholism
591
611
.
B. Van Sweden & M. Dumon-Radermecker. (1982) The EEG in Chronic Psychotropic Drug Intoxications. Clinical Electroencephalography 13:4, pages 206-215.
Crossref
John B. Marshall & Alan D. Forker. (1982) Cardiovascular effects of tricyclic antidepressant drugs: Therapeutic usage, overdose, and management of complications. American Heart Journal 103:3, pages 401-414.
Crossref
L. R. Hines. 1981. Psychotropic Agents. Psychotropic Agents
359
393
.
Richard C. W. Hall, Michael K. Popkin, Sondra K. Stickney & Earl R. Gardner. 1981. Drug Dependence and Alcoholism. Drug Dependence and Alcoholism
1129
1137
.
Paul Pentel & Charles D. Peterson. (1980) Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Annals of Emergency Medicine 9:11, pages 588-590.
Crossref
W.Marvin Davis & Nabil S. Hatoum. (1980) Synergism of the toxicity of physostigmine and neostigmine by lithium or by a reserpine-like agent (Ro4-1284). Toxicology 17:1, pages 1-7.
Crossref
P. Thomann & R. Hess. 1980. Psychotropic Agents. Psychotropic Agents
527
549
.
J. Roman Bastani. (1979) Physostigmine treatment of tricyclic overdosage in psychosis. Psychosomatics 20:12, pages 847-848.
Crossref
B. Sangster, A. Van Dijk & J. H. Glerum. (1979) Fysostigmine bij de behandeling van vergiftigingenPhysostigmine in the treatment of drug-intoxications. Pharmaceutisch weekblad 1:1, pages 345-350.
Crossref
Michael Callaham. (1979) Tricyclic antidepressant overdose. Journal of the American College of Emergency Physicians 8:10, pages 413-425.
Crossref
William K. SummersTheodore C. Reich. (1979) Delirium After Cataract Surgery: Review and Two Cases. American Journal of Psychiatry 136:4A, pages 386-391.
Crossref
Maurice W Dysken. (1978) Anticholinergic Psychosis. Psychiatric Annals 8:9, pages 30-42.
Crossref
William K. Summers. (1978) A clinical method of estimating risk of drug induced delirium. Life Sciences 22:17, pages 1511-1516.
Crossref
S.‐M. Aquilonius & U. Hedstrand. (2008) The Use of Physostigmine as an Antidote in Tricyclic Anti‐depressant Intoxication. Acta Anaesthesiologica Scandinavica 22:1, pages 40-45.
Crossref
S.-M. Aquilonius. 1978. Cholinergic Mechanisms and Psychopharmacology. Cholinergic Mechanisms and Psychopharmacology
817
825
.
Gary E. Hill, Theodore H. Stanley & Craig R. Sentker. (1977) Physostigmine reversal of postoperative somnolence. Canadian Anaesthetists’ Society Journal 24:6, pages 707-711.
Crossref
Moshe Rehavi, Saul Maayani & Mordechai Sokolovsky. (1977) Tricyclic antidepressants as antimuscarinic drugs: In vivo and in vitro studies. Biochemical Pharmacology 26:17, pages 1559-1567.
Crossref
Michael Sheehan & Patricia Haythorn. (1977) Combined thin-layer and gas-liquid chromatographic identification of tricyclic antidepressants in urine. Journal of Chromatography A 132:2, pages 237-247.
Crossref
Saul Maayani, Yaakov Egozi, Irit Pinchasi & Mordechai Sokolovsky. (1977) On the interaction of drugs with the cholinergic nervous system. Psychopharmacology 55:1, pages 43-48.
Crossref
Stephen P. Wright. (2016) Usefulness of Physostigmine in Imipramine Poisoning. Clinical Pediatrics 15:12, pages 1123-1128.
Crossref
R. S. HendersonC. McK. Holmes. (2019) Reversal of the Anaesthetic Action of Sodium Gamma-Hydroxybutyrate. Anaesthesia and Intensive Care 4:4, pages 351-354.
Crossref
T. C. K. Brown. (1976) SODIUM BICARBONATE TREATMENT FOR TRICYCLIC ANTIDEPRESSANT ARRHYTHMIAS IN CHILDREN. Medical Journal of Australia 2:10, pages 380-382.
Crossref
Candace K. Bryan, Judith A. Ludy, Sandra H. Hak, Rosemary Roberts & William R. Marshall. (2016) Overdoses with Tricyclic Antidepressants. Drug Intelligence & Clinical Pharmacy 10:7, pages 380-384.
Crossref
Philip B. Johnson. (1976) Physostigmine in tricyclic antidepressant overdose. Journal of the American College of Emergency Physicians 5:6, pages 443-445.
Crossref
William E. Walker, Richard C. Levy & Irwin B. Hanenson. (1976) Physostigmine — Its use and abuse. Journal of the American College of Emergency Physicians 5:6, pages 436-439.
Crossref
L. S. Chin, J. H. Havill, R. P. G. Rothwell & B. G. Bishop. (2019) Use of Physostigmine in Tricyclic Antidepressant Poisoning. Anaesthesia and Intensive Care 4:2, pages 138-140.
Crossref
Anthony S. Manoguerra & Ernest Ruiz. (1976) Physostigmine treatment of anticholinergic poisoning. Journal of the American College of Emergency Physicians 5:2, pages 125-127.
Crossref
Stephen N. Steen. (1976) The effects of psychotropic drugs on respiration. Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology 2:4, pages 717-741.
Crossref
A. G. Rauws & M. Olling. (1976) Treatment of experimental imipramine and desipramine poisoning in the rat. Archives of Toxicology 35:2, pages 97-106.
Crossref
T.C.K. BROWN. (1975) Overdosage - The rise and fall of tricyclic antidepressanls. Journal of Paediatrics and Child Health 11:3, pages 190-194.
Crossref
Byron C. Jones, Paul F. Consroe & Faren Akins. (2013) Physostigmine-induced reversal of EEG and behavioral effects of ?9-tetrahydrocannabinol. Bulletin of the Psychonomic Society 6:2, pages 204-206.
Crossref
WILLIAM E. THORNTON & BONNIE J. PRAY. (2013) Combination Drug Therapy in Psychopharmacology. The Journal of Clinical Pharmacology 15:7, pages 511-517.
Crossref
Rodrigo A. Munoz & James B. Kuplic. (1975) Large Overdose of Tricydic Antidepressants Treated With Physostigmine Salicylate. Psychosomatics 16:2, pages 77-78.
Crossref
J. Buus Lassen, R. F. Squires, J. A. Christensen & L. Molander. (1975) Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties. Psychopharmacologia 42:1, pages 21-26.
Crossref
T. C. K. Brown, F. I. Bishop & G. C. Mullins. (2019) Drug Overdosage in Children. Anaesthesia and Intensive Care 2:4, pages 303-309.
Crossref
Robert G. Pietrusko. (2016) Physostigmine in Amitriptyline Overdose. Drug Intelligence & Clinical Pharmacy 8:3, pages 144-144.
Crossref
John M Davis. (1973) OVERDOSE OF PSYCHOTROPIC DRUGS. Psychiatric Annals 3:6, pages 6-6.
Crossref